Letter to the Editor regarding 'Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study'.
作者信息
Medhekar Rohan, Clark Laura, Gautam Santosh, Cortoos Annelore
机构信息
Johnson & Johnson, Horsham, PA, USA.
出版信息
Drug Deliv. 2025 Dec;32(1):2537813. doi: 10.1080/10717544.2025.2537813. Epub 2025 Aug 4.
Abstract
摘要
相似文献
1
Letter to the Editor regarding 'Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study'.致编辑的信：关于“评估护士对新型体内给药系统与手动注射器用于大容量皮下药物注射的偏好：一项调查研究”
Drug Deliv. 2025 Dec;32(1):2537813. doi: 10.1080/10717544.2025.2537813. Epub 2025 Aug 4.
2
Letter to the Editor regarding 'Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study'.致编辑的信：关于“评估护士对用于大容量皮下给药的新型体内给药系统与手动注射器的偏好：一项调查研究”
Drug Deliv. 2025 Dec;32(1):2537818. doi: 10.1080/10717544.2025.2537818. Epub 2025 Jul 29.
3
Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study.评估护士对于用于大容量皮下给药的新型体内给药系统与手动注射器的偏好：一项调查研究。
Drug Deliv. 2025 Dec;32(1):2484278. doi: 10.1080/10717544.2025.2484278. Epub 2025 Apr 3.
4
Factors influencing the acceptability of different devices for subcutaneous drug delivery: a cross-sectional observational study from the patient's point of view.影响皮下药物输送不同装置可接受性的因素：一项来自患者角度的横断面观察性研究。
Eur J Hosp Pharm. 2024 Jun 21;31(4):348-351. doi: 10.1136/ejhpharm-2022-003477.
5
Subcutaneous administration of isatuximab in patients with multiple myeloma by an on-body delivery system: results of a nurse survey.通过体内给药系统对多发性骨髓瘤患者皮下注射isatuximab：护士调查结果
Front Oncol. 2025 Jun 18;15:1547108. doi: 10.3389/fonc.2025.1547108. eCollection 2025.
6
Response to letter to the editor regarding 'Construction of a predictive model for relapse of primary autoimmune hemolytic anemia: a retrospective cohort study'.对致编辑信的回复，信的主题为“原发性自身免疫性溶血性贫血复发预测模型的构建：一项回顾性队列研究”
Ann Med. 2025 Dec;57(1):2533430. doi: 10.1080/07853890.2025.2533430. Epub 2025 Jul 17.
7
Therapeutic delivery - industry update covering October 2024.治疗性给药——2024年10月行业动态更新
Ther Deliv. 2025 Feb;16(2):117-122. doi: 10.1080/20415990.2025.2463312. Epub 2025 Feb 17.
8
Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.使用移动应用程序与其他方法收集的自我管理调查问卷回复的比较。
Cochrane Database Syst Rev. 2015 Jul 27;2015(7):MR000042. doi: 10.1002/14651858.MR000042.pub2.
9
Letter to the editor regarding: 'Construction of a predictive model for relapse of primary autoimmune hemolytic anemia: a retrospective cohort study'.致编辑的信：关于“构建原发性自身免疫性溶血性贫血复发预测模型：一项回顾性队列研究”
Ann Med. 2025 Dec;57(1):2523566. doi: 10.1080/07853890.2025.2523566. Epub 2025 Jun 23.
10
Population Pharmacokinetics of Epcoritamab Following Subcutaneous Administration in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma.皮下注射依泊妥单抗治疗复发或难治性B细胞非霍奇金淋巴瘤后的群体药代动力学
Clin Pharmacokinet. 2025 Jan;64(1):127-141. doi: 10.1007/s40262-024-01464-2. Epub 2024 Dec 21.
本文引用的文献
1
Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study.评估护士对于用于大容量皮下给药的新型体内给药系统与手动注射器的偏好：一项调查研究。
Drug Deliv. 2025 Dec;32(1):2484278. doi: 10.1080/10717544.2025.2484278. Epub 2025 Apr 3.
2
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.达雷妥尤单抗、硼替佐米、来那度胺和地塞米松治疗多发性骨髓瘤。
N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12.
Zotero 插件